Cargando…

Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization

SIMPLE SUMMARY: Patients treated with chimeric antigen receptor T-cell therapy (CAR-T) are at risk for severe toxicities post-treatment. Patient-reported outcomes and activity data from fitness trackers could be helpful for monitoring patients after CAR-T. The aim of this pilot study was to test the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oswald, Laura B., Li, Xiaoyin, Carvajal, Rodrigo, Hoogland, Aasha I., Gudenkauf, Lisa M., Hansen, Doris K., Alsina, Melissa, Locke, Frederick L., Rodriguez, Yvelise, Irizarry-Arroyo, Nathaly, Robinson, Edmondo J., Jim, Heather S. L., Gonzalez, Brian D., Kirtane, Kedar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179384/ https://www.ncbi.nlm.nih.gov/pubmed/35681722 http://dx.doi.org/10.3390/cancers14112742

Ejemplares similares

Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel
por: Oswald, Laura B., et al.
Publicado: (2023)

QUALITY OF LIFE IN OLDER ADULTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
por: Hoogland, Aasha I, et al.
Publicado: (2019)

“I have cancer during COVID; that’s a special category”: a qualitative study of head and neck cancer patient and provider experiences during the COVID-19 pandemic
por: Kirtane, Kedar, et al.
Publicado: (2022)

Smoking Is Related to Worse Cancer-related Symptom Burden
por: Oswald, Laura B, et al.
Publicado: (2022)

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel
por: Hoogland, Aasha I., et al.
Publicado: (2021)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
por: Locke, Frederick L., et al.
Publicado: (2017)

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
por: Rejeski, Kai, et al.
Publicado: (2023)

How I treat cytopenias after CAR T-cell therapy
por: Jain, Tania, et al.
Publicado: (2023)

Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison
por: Hoogland, Aasha I., et al.
Publicado: (2023)

Patient-Reported Outcomes as Interradiographic Predictors of Response in Non–Small Cell Lung Cancer
por: Bhatt, Ambika S., et al.
Publicado: (2023)

Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
por: Cheng, Rebecca, et al.
Publicado: (2021)

Correction to ‘The roles of T-cell competition and stochastic extinction events in CAR T-cell therapy’
por: Kimmel, Gregory J., et al.
Publicado: (2022)

Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors
por: Jim, Heather S. L., et al.
Publicado: (2020)

Alcohol and prescription drug safety in older adults
por: Zanjani, Faika, et al.
Publicado: (2013)

Mediport use as an acceptable standard for CAR T cell infusion
por: Eylon, Maya, et al.
Publicado: (2023)

Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
por: Tometich, Danielle B., et al.
Publicado: (2023)

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
por: Kirtane, Kedar, et al.
Publicado: (2018)

Introduction to data science: data analysis and prediction algorithms with R
por: Irizarry, Rafael A
Publicado: (2020)

The Car Cushion Hypothesis: Bigger Cars Lead to More Risk Taking—Evidence from Behavioural Data
por: Claus, B., et al.
Publicado: (2022)

A Data Correction Algorithm for Low-Frequency Floating Car Data
por: Li, Bijun, et al.
Publicado: (2018)

The ADAMO data system: EXA, the cars example
por: Fisher, S M, et al.
Publicado: (1992)

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL
por: Perez, Ariel, et al.
Publicado: (2022)

Pilot randomized controlled trial of eHealth cognitive-behavioral therapy for insomnia among Spanish-speaking breast cancer survivors
por: Oswald, Laura B., et al.
Publicado: (2022)

Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
por: Gudenkauf, Lisa M., et al.
Publicado: (2023)

CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response
por: Akhtar, Othman S., et al.
Publicado: (2023)

P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIENTS: A SINGLE CENTER EXPERIENCE
por: Din, Mohammad Ammad Ud, et al.
Publicado: (2023)

Toxicogenomics Data: The Road to Acceptance
por: Freeman, Kris
Publicado: (2004)

Associations among Depression, Antidepressants, Survival and Quality of Life in Hematopoietic Cell Transplant Recipients
por: Barata, Anna, et al.
Publicado: (2020)

Patient‐reported symptom burden in routine oncology care: Examining racial and ethnic disparities
por: Bulls, Hailey W., et al.
Publicado: (2021)

Hyperspectral image analysis for CARS, SRS, and Raman data
por: Masia, Francesco, et al.
Publicado: (2015)

CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production
por: Abraham-Miranda, Julieta, et al.
Publicado: (2022)

Patient-Reported Outcomes in Cancer Patients with HIV
por: Coghill, Anna E., et al.
Publicado: (2022)

Journals accepting case reports
por: Gotschall, Terri, et al.
Publicado: (2023)

Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma
por: Muzaffar, Jameel, et al.
Publicado: (2021)

Data analysis for the life sciences with R
por: Irizarry, Rafael A, et al.
Publicado: (2016)

Blockchain-Based Data Sharing and Trading Model for the Connected Car
por: Jeong, Byeong-Gyu, et al.
Publicado: (2020)

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
por: Rejeski, Kai, et al.
Publicado: (2023)

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
por: Kirtane, Kedar, et al.
Publicado: (2021)

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
por: Rejeski, Kai, et al.
Publicado: (2022)

An acceptance divergence? Media, citizens and policy perspectives on autonomous cars in the European Union
por: dos Santos, Fabio Luis Marques, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_deslmcm9hormbm0ia8g8pp3djh